Skip to main content

Table 2 Predictors of log NT-proBNP in multivariate regression analysis

From: B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function

Variables Predictors of log BNP Predictors of log NT-proBNP
  B standardized coefficient Confidence Interval p value B standardized coefficient Confidence Interval p value
Age 0.055 −0.003 to 0.007 0.40 −0.108 −0.011 to 0.000 0.03
Creatinine −0.030 −0.054 to 0.038 0.74 −0.079 −0.085 to 0.024 0.26
Body Mass Index 0.008 −0.014 to 0.031 0.46 0.104 0.003 to 0.053 0.02
Duration of kidney disease 0.095 0.000 to 0.004 0.12 −0.029 −0.003 to 0.002 0.53
Heart Failure −0.134 −0.445 to 0.147 0.32 0.262 0.077 to 0.800 0.01
NYHA stage 0.075 −0.089 to 0.165 0.55 0.634 0.368 to 0.617 0.00
Ejection fraction 0.045 −0.008 to 0.010 0.76 0.138 −0.004 to 0.017 0.22
eGFR 0.070 −0.005 to 0.011 0.48 −0.468 −0.036 to −0.019 0.00
Log BNP/NT-proBNP 0.729 0.358 to 0.615 0.00 0.468 0.341 to 0.595 0.00
  1. Abbreviations: BNP b-type natriuretic peptide, NT-proBNP amino terminal B-type natriuretic peptide, NYHA New York Heart Association, eGFR estimated glomerular filtration rate, ARB angiotensin receptor blocker.
  2. p-value <0.05 statistically significant.